India has come a long way in becoming a hub for manufacturing and supply of generic drugs and has been lauded for its drive and efforts in becoming the pharmacy of the world. We have seen pharma innovation advance at an incredible pace to tackle the COVID-19 pandemic. Despite being the third largest seller of medicines in the world, India has been able to produce only a handful of novel commercially viable drugs and still have a long way to go in terms of its activities in commercially oriented R&D and innovations. As the need for improved productivity and efficiency in drug and biomedical R&D intensifies, pharmaceutical companies carefully choose their investment in technology innovation. The India Biopharma Leaders Conclave will bring together decision makers, industry and technology experts and influencers to share insights and best practices on how to effectively deliver value and showcase the latest technological advancements and innovative solutions to tackle current and future challenges to cut costs, increase productivity and stay ahead of the world while meeting global standards.